These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 7229991)

  • 21. Effects of AHR-2666 on electrical activity of canine cardiac tissues: possible inhibition of slow inward current.
    Siegal MS; Gliklich JI; Mary-Rabine L; Hoffman BF
    J Pharmacol Exp Ther; 1979 Dec; 211(3):606-14. PubMed ID: 512920
    [No Abstract]   [Full Text] [Related]  

  • 22. Cardiovascular effects of (2RS,3SR)- 2-aminomethyl-2,3,7,8-tetrahydro-2,3,5,8,8-pentamethyl-6H-furo- [2,3-e]indol-7-one hydrochloride (UK-1745), a novel cardiotonic agent with vasodilatory and antiarrhythmic properties.
    Uchida Y; Kawada M; Sawanobori K; Sonoki H; Inoue K; Mizuno K; Itou T; Tabunoki Y; Tsukamoto M; Ohashi Y; Kyotani Y; Shimizu N; Fujii M; Nakamura M
    Arzneimittelforschung; 1998 Mar; 48(3):219-31. PubMed ID: 9553677
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of gallium chloride on changes in action potentials and contraction in guinea pig ventricular muscle.
    Kantelip JP; Millart H; Leperre A; Mougin F; Didier JM
    Anticancer Res; 1996; 16(1):327-32. PubMed ID: 8615630
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of verapamil on electrophysiologic properties of canine cardiac Purkinje fibers.
    Rosen MR; Ilvento JP; Gelband H; Merker C
    J Pharmacol Exp Ther; 1974 May; 189(2):414-22. PubMed ID: 4829223
    [No Abstract]   [Full Text] [Related]  

  • 25. Electrophysiological effects of GYKI-23 107, a new antiarrhythmic compound, in isolated rabbit and canine cardiac preparations.
    Varró A; Németh M; Rabloczky G; Papp JG; Szekeres L
    J Cardiovasc Pharmacol; 1988 Mar; 11(3):251-7. PubMed ID: 2452917
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effects of Viscum coloratum flavonoids on fast response action potentials of hearts].
    Wu JX; Yu GR; Wang BY; Zhong DS; Huang DJ
    Zhongguo Yao Li Xue Bao; 1994 Mar; 15(2):169-72. PubMed ID: 8010115
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Electrophysiological studies of 6-(N,N-diethylamino)-Hexyl-3,4,5,-Trimethoxybenzoate on ventricular muscle and conduction system.
    Posner P; Chiou CY
    Pharmacology; 1976; 14(2):97-103. PubMed ID: 959320
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of ouabain on canine Purkinje fibers in situ or perfused with blood.
    Rosen MR; Gelband H
    J Pharmacol Exp Ther; 1973 Aug; 186(2):366-72. PubMed ID: 4719789
    [No Abstract]   [Full Text] [Related]  

  • 29. Effects of therapeutic and toxic doses of ouabain on automaticity in the blood-perfused canine papillary muscle preparation.
    Hashimoto K; Kimura T; Endo M
    J Pharmacol Exp Ther; 1972 Sep; 182(3):388-98. PubMed ID: 5055402
    [No Abstract]   [Full Text] [Related]  

  • 30. Failure of potassium canrenoate to alter experimentally induced digitalis arrhythmias.
    Lucchesi BR; Haley NR
    Eur J Pharmacol; 1973 Jun; 22(3):256-62. PubMed ID: 4732564
    [No Abstract]   [Full Text] [Related]  

  • 31. Electrophysiological effects of changrolin, a new antiarrhythmic drug, on isolated cardiac preparations.
    Xu YQ; Carmeliet E
    Arch Int Pharmacodyn Ther; 1981 Oct; 253(2):333-4. PubMed ID: 7325772
    [No Abstract]   [Full Text] [Related]  

  • 32. Cardiac electrophysiologic effect of indomethacin.
    Posner P; Peterson CV
    Eur J Pharmacol; 1982 Jan; 77(2-3):193-5. PubMed ID: 7060636
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of aprindine and lidocaine on transmembrane potentials and radioactive K efflux in different cardiac tissues.
    Carmeliet E; Verdonck F
    Acta Cardiol; 1974; Suppl 18():73-90. PubMed ID: 4547403
    [No Abstract]   [Full Text] [Related]  

  • 34. Cardiac arrhythmias in sensitized hearts - primary mechanisms involved.
    Reynolds AK
    Res Commun Chem Pathol Pharmacol; 1983 Apr; 40(1):3-14. PubMed ID: 6867471
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative myocardial depressant and anti-arrhythmic properties of d-propranolol, dl-propranolol and quinidine.
    Parmley WW; Braunwald E
    J Pharmacol Exp Ther; 1967 Oct; 158(1):11-21. PubMed ID: 6054071
    [No Abstract]   [Full Text] [Related]  

  • 36. Arrhythmogenic and antiarrhythmic actions of substances of abuse: effects on triggered activity.
    Gallardo-Carpentier A; Aileru AA; Carpentier RG
    J Electrocardiol; 1997 Apr; 30(2):137-42. PubMed ID: 9141609
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Electrophysiologic actions of UM-272 (Pranolium) on reentrant ventricular arrhythmias in postinfarction canine myocardium.
    Gibson JK; Lucchesi BR
    J Pharmacol Exp Ther; 1980 Aug; 214(2):347-53. PubMed ID: 7391982
    [No Abstract]   [Full Text] [Related]  

  • 38. Comparison of the effects of restacorin and flecainide on various cardiac transmembrane potassium currents.
    Németh M; Virág L; Varró A; Papp JG
    Acta Physiol Hung; 1996; 84(3):317-8. PubMed ID: 9219622
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effects of resibufogenin on membrane responsiveness and afterpotential of human and canine myocardial cells].
    Xie JT; Belic N; McCullough J; Singer DH
    Zhongguo Yao Li Xue Bao; 1985 Dec; 6(4):254-8. PubMed ID: 2945365
    [No Abstract]   [Full Text] [Related]  

  • 40. Electrophysiological effects of haloperidol on isolated rabbit Purkinje fibers and guinea pigs papillary muscles under normal and simulated ischemia.
    Yan D; Cheng LF; Song HY; Turdi S; Kerram P
    Acta Pharmacol Sin; 2007 Aug; 28(8):1155-60. PubMed ID: 17640477
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.